Novo Nordisk’s game-changing oral diabetes drug clears Phase II

By on 23rd of February 2015

Novo Nordisk’s new oral diabetes drug measured up to its injected counterpart in a midstage study, promising results the company heralds as a milestone in the field.The drug, called OG217SC, is an oral version of Novo’s semaglutide, now in Phase III development as a weekly subcutaneous treatment. Each acts as an analog of the hormone GLP-1 to promote the body’s natural production of insulin, spurring weight loss and relieving the symptoms of Type 2 diabetes.And the oral version did just that in Phase II, Novo said.

Read more

Microscopic stealth drones could soon be repairing your blood vessels

By Breakingnews.ie on 23rd of February 2015

Here’s a sentence that’s straight out of the future: Microscopic stealth drones could be repairing your damaged arteries very soon.That’s right. Scientists are developing tiny man-made particles that can whizz around in your blood fixing the damage that causes heart attacks and strokes.

Read more

How to build a star

By The Week on 23rd of February 2015

Deep in the French countryside, some of the world’s cleverest scientists are building a vast thermonuclear reactor. If all goes well, says Alok Jha, this “star in a box” could be the key to providing clean, safe energy for the next centuryThe countryside of Saint-Paul-lez-Durance in Provence is a picture-perfect terrain of wooded hills and vineyards, beneath a bright blue winter sky. It seems incongruous that this is where the most sophisticated, expensive machine ever built is slowly taking shape, at the local Cadarache nuclear facility.

Read more

Pages